Evommune, Inc. (EVMN) - Latest Market Data

Price & Market Data

Price: $22.69

Daily Change: -$0.52 / 2.29%

Daily Range: $22.34 - $23.84

Market Cap: $817,256,896

Daily Volume: 260,101

Performance Metrics

1 Week: -6.08%

1 Month: -15.99%

3 Months: -21.84%

6 Months: 23.25%

1 Year: 31.54%

YTD: 32.54%

About Evommune, Inc. (EVMN)

Your go-to source for Evommune, Inc. (EVMN) market data. Current price: 22.69, daily change: -$0.52 / 2.29%. Market cap: 817,256,896. All essential performance metrics are here, from 1-month to 1-year.

Company Details

Employees: 48

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.

Selected stocks

MaxLinear, Inc (MXL)

Digital Asset Acquisition Corp. (DAAQU)

Network-1 Technologies, Inc. (NTIP)

Vyome Holdings, Inc. (HIND)